通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600763 通策医疗

已收盘 06-08 15:00:00

{"stockData":{"symbol":"600763","market":"SH","secType":"STK","nameCN":"通策医疗","latestPrice":33.83,"timestamp":1780902001000,"preClose":35,"halted":0,"volume":7667152,"delay":0,"changeRate":-0.0334,"floatShares":447000000,"shares":447000000,"eps":1.1288,"marketStatus":"已收盘","change":-1.17,"latestTime":"06-08 15:00:00","open":34.55,"high":35.2,"low":33.61,"amount":262000000,"amplitude":0.0454,"askPrice":33.83,"askSize":45,"bidPrice":33.82,"bidSize":25,"shortable":0,"etf":0,"ttmEps":1.1288,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780968600000},"marketStatusCode":5,"adr":0,"adjPreClose":35,"symbolType":"stock","openAndCloseTimeList":[[1780882200000,1780889400000],[1780894800000,1780902000000]],"highLimit":38.5,"lowLimit":31.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447289117,"isCdr":false,"pbRate":3.42,"roa":"--","peRate":29.96988,"roe":"4.32%","epsLYR":1.12,"committee":0.358639,"marketValue":15132000000,"turnoverRate":0.0171,"status":1,"floatMarketCap":15132000000},"requestUrl":"/m/hq/s/600763","defaultTab":"news","newsList":[{"id":"2641348116","title":"通策医疗：6月5日董事黄浴华增持股份合计5700股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641348116","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641348116?lang=zh_cn&edition=full","pubTime":"2026-06-08 20:01","pubTimestamp":1780920101,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月8日市场公开信息、上市公司公告及交易所披露数据整理，通策医疗最新董监高及相关人员股份变动情况：2026年6月5日公司董事黄浴华共增持公司股份5700.0股，占公司总股本为0.0013%。变动期间公司股价上涨0.75%，6月5日当日收盘报35.0元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800031138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0096","BK0077","BK0048","BK0284","BK0236","600763","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127541","title":"每周股票复盘：通策医疗（600763）董事黄浴华增持1.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127541","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127541?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:22","pubTimestamp":1780770132,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，通策医疗报收于35.0元，较上周的37.41元下跌6.44%。本周，通策医疗6月1日盘中最高价报37.56元。6月4日盘中最低价报34.73元，股价触及近一年最低点。通策医疗当前最新总市值156.55亿元，在医疗服务板块市值排名10/51，在两市A股市值排名1341/5206。本周关注点股本股东变化：董事黄浴华于6月4日增持公司股份1.46万股。变动期间公司股价下跌1.42%，6月4日当日收盘报34.74元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0048","BK0284","BK0236","BK0114","600763","BK0096","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110607","title":"通策医疗：6月4日董事黄浴华增持股份合计1.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110607","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641110607?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:01","pubTimestamp":1780660910,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月5日市场公开信息、上市公司公告及交易所披露数据整理，通策医疗最新董监高及相关人员股份变动情况：2026年6月4日公司董事黄浴华共增持公司股份1.46万股，占公司总股本为0.0033%。变动期间公司股价下跌1.42%，6月4日当日收盘报34.74元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500036914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0146","BK0096","BK0114","BK0236","BK0284","600763","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163906","title":"通策医疗最新公告：拟5000万元至1亿元回购股份用于注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640163906?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:02","pubTimestamp":1780484525,"startTime":"0","endTime":"0","summary":"通策医疗(600763.SH)公告称，公司拟以集中竞价交易方式回购股份，资金总额不低于5000万元且不超过1亿元，回购价格不超过60.12元/股，用于减少公司注册资本(注销股份)。回购期限自股东会审议通过之日起12个月内，资金来源为自有资金或自筹资金。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300040345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763","BK0077","BK0114","BK0048","BK0284","BK0096","BK0146","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640471979","title":"股市必读：通策医疗（600763）6月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640471979","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640471979?lang=zh_cn&edition=full","pubTime":"2026-06-03 01:38","pubTimestamp":1780421893,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，通策医疗报收于36.81元，下跌1.97%，换手率1.18%，成交量5.28万手，成交额1.96亿元。董秘最新回复投资者： 请问贵司是否有去香港上市计划？最近很多A股公司都去港股上市，包括爱尔眼科也要去港股了，我们大通策是否也有这个计划呢？来自交易信息汇总：散户资金净流入2645.53万元，占总成交额13.53%，显著高于主力与游资流出规模。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300001822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","600763","BK0146","BK0236","BK0284","BK0114","BK0077","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640983944","title":"股市必读：通策医疗（600763）5月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640983944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640983944?lang=zh_cn&edition=full","pubTime":"2026-06-01 01:35","pubTimestamp":1780248912,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，通策医疗报收于37.41元，上涨2.72%，换手率2.15%，成交量9.6万手，成交额3.58亿元。董秘最新回复投资者： 最近股价一直下跌，是有什么原因吗？近期股价波动主要受市场情绪及多重因素影响。当日关注点来自交易信息汇总：5月29日主力资金净流入3998.0万元，占总成交额11.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100000670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763","BK0236","BK0114","BK0284","BK0146","BK0077","BK0048","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639012396","title":"每周股票复盘：通策医疗（600763）控股股东质押股份占其持股65.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639012396","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639012396?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:04","pubTimestamp":1780164254,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，通策医疗报收于37.41元，较上周的37.0元上涨1.11%。本周关注点公司公告汇总：控股股东宝群实业剩余被质押股份占其持股总数的65.17%，占公司总股本的22.09%。本次解除质押股份数为2,250,000股，占宝群实业所持本公司股份的1.48%，占公司总股本的0.50%。宝群实业及其一致行动人吕建明先生合计持股占公司总股本的34.36%，已质押股份占其合计持股的64.28%。控股股东质押股份中，未来半年内到期的占其所持股份的38.79%，未来一年内到期的占50.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0146","BK0096","BK0114","BK0236","BK0284","600763","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638168625","title":"通策医疗（600763）披露控股股东部分股票解除质押公告，5月27日股价上涨2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638168625","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638168625?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:16","pubTimestamp":1779891379,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，通策医疗报收于37.3元，较前一交易日上涨2.47%，最新总市值为166.84亿元。近日，通策医疗股份有限公司发布《关于控股股东部分股票解除质押的公告》。本次解除质押股份数为2,250,000股，占宝群实业所持本公司股份的1.48%，占公司总股本的0.50%。解除质押后，宝群实业剩余被质押股份数为98,786,672股，占其持股总数的65.17%，占公司总股本的22.09%。宝群实业及其一致行动人吕建明先生合计持股占公司总股本的34.36%，已质押股份占其合计持股的64.28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700045945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","BK0114","BK0048","BK0077","600763","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634295551","title":"“牙茅”为何收购眼镜公司，通策医疗独家回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2634295551","media":"中金财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634295551?lang=zh_cn&edition=full","pubTime":"2026-05-12 15:48","pubTimestamp":1778572117,"startTime":"0","endTime":"0","summary":"5月11日下午，在茅指数中被称为“牙茅”的通策医疗在上证路演中心召开了2025年年度和2026年一季度业绩暨现金分红说明会。营业总收入扣除营业成本和各项费用后，归母净利润1.87亿元，同比增长1.66%。　　而近期该公司受到外界的广泛关注，原因之一还在于通策医疗已公告拟以6亿元自有资金收购大股东吕建明控制下的四家眼视光公司100%股权，其中核心标的即为杭州存济眼镜有限公司。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202605/12/20260512190851.jpeg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202605/12/20260512190851.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260512/32217775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0048","600763","BK0284","BK0146","BK0096","BK0077","BK0236","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630809088","title":"每周股票复盘：通策医疗（600763）蒲公英医院2026年目标营收增48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630809088","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630809088?lang=zh_cn&edition=full","pubTime":"2026-04-26 01:47","pubTimestamp":1777139229,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，通策医疗报收于43.23元，较上周的41.21元上涨4.9%。本周，通策医疗4月24日盘中最高价报44.5元。本周关注点来自机构调研要点：蒲公英医院2026年目标整体营收同比增长48%。全年门诊量 357.36 万人次，同比增长 1.14%。答：2025 年蒲公英医院共 49家，实现收入 8.56亿元，占公司总营收 31%，同比增长 20%；毛利率 28%，净利润 9236 万元，同比增长 95%。2026 年一季度蒲公英医院营收 2.23 亿元，同比增长 17%；净利润 4400 万元，同比增长 24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629745200","title":"国金证券：给予通策医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629745200","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629745200?lang=zh_cn&edition=full","pubTime":"2026-04-23 08:05","pubTimestamp":1776902753,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕近期对通策医疗进行研究并发布了研究报告《业绩平稳增长，营销改革有望贡献新增量》，给予通策医疗增持评级。　　通策医疗　　业绩简评　　2026年4月17日，公司发布2025年年报及2026年第一季度报告。经营活动产生的现金流量净额为8.11亿元，同比增长6.2%，经营质量优异。正畸业务2025年收入5.10亿元，同比增长7.63%，正畸业务呈现明确复苏态势。全年病例量同比增长10.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300020302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629054890","title":"股市必读：通策医疗（600763）4月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2629054890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629054890?lang=zh_cn&edition=full","pubTime":"2026-04-22 02:22","pubTimestamp":1776795729,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，通策医疗报收于40.79元，下跌0.68%，换手率1.34%，成交量6.01万手，成交额2.46亿元。2026 年一季度实现营业收入 7.55 亿元，同比增长 1.43%；归母净利润 1.87 亿元，同比增长 1.66%；扣非净利润 1.85亿元，同比增长 1.37%；经营活动现金流 1.61 亿元，同比增长 9.07%。省内医疗服务收入 25.15 亿元，同比增长 2.1%；省外 2.49亿元，同比下降 7.11%。全年门诊量 357.36 万人次，同比增长 1.14%。2026 年一季度蒲公英医院营收 2.23 亿元，同比增长 17%；净利润 4400 万元，同比增长 24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200005895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0114","BK0048","BK0236","BK0284","BK0096","600763","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629018087","title":"通策医疗：华创证券、天风证券等多家机构于4月20日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2629018087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629018087?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:19","pubTimestamp":1776766764,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年4月21日通策医疗发布公告称华创证券郑辰 王宏雨、天风证券杨松 刘一伯、中泰证券祝嘉琦 杨涛、东吴证券朱国广 冉胜男、开源证券余汝意 阮帅、中信证券陈竹 宋硕 沈睦钧于2026年4月20日调研我司。通策医疗2026年一季报显示，一季度公司主营收入7.55亿元，同比上升1.43%；归母净利润1.87亿元，同比上升1.66%；扣非净利润1.85亿元，同比上升1.37%；负债率23.29%，投资收益880.6万元，财务费用823.28万元，毛利率43.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100042175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0284","BK0114","BK0048","BK0236","600763","161027","BK0146","BK0096","BK0077","601162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629566087","title":"“牙茅”通策医疗2025年营收、利润微增，6亿收购实控人眼镜公司遭问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2629566087","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629566087?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:07","pubTimestamp":1776766077,"startTime":"0","endTime":"0","summary":"年报显示，通策医疗营收与净利润均只有微幅增长。而在此背景下，近日，通策医疗披露拟以6亿元现金收购上市公司实控人吕建明控制下的杭州存济眼镜、宁波广济眼视光、杭州广济眼视光、新昌广济眼镜4家眼视光公司，引发上交所发函追问和市场关注。通策医疗预计，杭州存济眼镜近年来各类眼镜销量持续攀升，2026年至2028年的主营业务收入分别将达到1.65亿元、1.77亿元、1.85亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776765932176249755","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629736707","title":"开源证券：给予通策医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629736707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629736707?lang=zh_cn&edition=full","pubTime":"2026-04-21 14:15","pubTimestamp":1776752116,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对通策医疗进行研究并发布了研究报告《公司信息更新报告：2026Q1业绩稳健增长，期待营销改革落地》，给予通策医疗买入评级。最新盈利预测明细如下：该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为67.0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100028866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628749044","title":"通策医疗（600763）披露2025年利润分配公告，4月20日股价下跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628749044","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628749044?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:59","pubTimestamp":1776679152,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，通策医疗报收于41.07元，较前一交易日下跌0.34%，最新总市值为183.7亿元。该股当日开盘40.95元，最高41.6元，最低40.38元，成交额达4.11亿元，换手率为2.25%。近日，通策医疗股份有限公司发布《关于2025年利润分配的公告》。公告显示，公司2025年度合并报表归属上市公司股东净利润为501,945,804.29元，母公司累计可供分配利润为1,041,817,621.72元。该利润分配方案尚需提交公司股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000026416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0236","BK0077","BK0284","BK0114","BK0146","600763","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628647207","title":"业绩增长乏力，“牙茅”通策医疗押注眼科前景几何","url":"https://stock-news.laohu8.com/highlight/detail?id=2628647207","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628647207?lang=zh_cn&edition=full","pubTime":"2026-04-19 20:17","pubTimestamp":1776601020,"startTime":"0","endTime":"0","summary":"　　4月18日，国内口腔医疗服务龙头企业通策医疗交出了2025年以及2026年一季度的成绩单。近年来，在种植牙集采及口腔医疗市场进入调整期的影响下，通策医疗业绩增长出现乏力迹象。　　财务数据显示，通策医疗2025年实现营业收入29.13亿元，同比增长1.37%；归属净利润5.02亿元，同比增长0.19%。　　主营业务增长引擎动力不足，通策医疗将目光投向了眼科。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-04-19/doc-inhuzxas0334398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0048","600763","BK0146","BK0236","BK0284","BK0114","BK0077","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756439","title":"每周股票复盘：通策医疗（600763）一季度净利增1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756439","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756439?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:45","pubTimestamp":1776534311,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，通策医疗报收于41.21元，较上周的42.13元下跌2.18%。本周关注点来自业绩披露要点：通策医疗2026年一季度归母净利润1.87亿元，同比上升1.66%。股本股东变化股东户数变动截至2026年3月31日，通策医疗股东户数为9.05万户，较2月10日增加2049户，增幅2.32%。业绩披露要点财务报告通策医疗2026年一季报显示，主营收入7.55亿元，同比上升1.43%；归母净利润1.87亿元，同比上升1.66%；扣非净利润1.85亿元，同比上升1.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0048","600763","BK0236","BK0114","BK0096","BK0077","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628373252","title":"通策医疗(600763)3月31日股东户数9.05万户，较上期增加2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628373252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628373252?lang=zh_cn&edition=full","pubTime":"2026-04-18 17:03","pubTimestamp":1776503003,"startTime":"0","endTime":"0","summary":"证券之星消息，近日通策医疗披露，截至2026年3月31日公司股东户数为9.05万户，较2月10日增加2049.0户，增幅为2.32%。在医疗服务行业个股中，通策医疗股东户数高于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.56万户。从股价来看，2026年2月10日至2026年3月31日，通策医疗区间跌幅为13.4%，在此期间股东户数增加2049.0户，增幅为2.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800018472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0114","BK0048","BK0236","600763","BK0146","BK0096","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628785674","title":"图解通策医疗一季报：第一季度单季净利润同比增长1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628785674","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628785674?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:17","pubTimestamp":1776446250,"startTime":"0","endTime":"0","summary":"证券之星消息，通策医疗2026年一季报显示，一季度公司主营收入7.55亿元，同比上升1.43%；归母净利润1.87亿元，同比上升1.66%；扣非净利润1.85亿元，同比上升1.37%；负债率23.29%，投资收益880.6万元，财务费用823.28万元，毛利率43.87%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800002644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780935753223,"stockEarnings":[{"period":"1week","weight":-0.0991},{"period":"1month","weight":-0.1819},{"period":"3month","weight":-0.2822},{"period":"6month","weight":-0.1785},{"period":"1year","weight":-0.1847},{"period":"ytd","weight":-0.1587}],"compareEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.0528},{"period":"3month","weight":-0.0397},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1695},{"period":"ytd","weight":-0.0024}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通策医疗股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"90448人(较上一季度减少0.07%)","perCapita":"4945股","listingDate":"1996-10-30","address":"浙江省杭州市上城区平海路57号","registeredCapital":"44728万元","survey":"　　通策医疗股份有限公司的主营业务是医疗器械、日用品、消毒用品的销售，投资管理，经营进出口业务，技术开发、技术咨询和技术服务，培训服务(不含办培训班)。公司的主要产品是医疗服务、产品销售、建设工程。公司连续七年（2018-2024年）获评德勤中国“中国卓越管理公司”，并于2025年荣膺该评选的“白金奖”、2026年获“杭州上城区经济高质量发展先进集体”，旗下杭州口腔医院荣获2025年度杭州市政府质量奖。","listedPrice":4.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通策医疗,600763,通策医疗股票,通策医疗股票老虎,通策医疗股票老虎国际,通策医疗行情,通策医疗股票行情,通策医疗股价,通策医疗股市,通策医疗股票价格,通策医疗股票交易,通策医疗股票购买,通策医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}